Eurasian Natural Resources Set to Go Private at 234 Pence a Share
Eurasian Natural Resources is to be bought by its founders and the government of Kazakhstan.
Regulator Identifies £3bn Capital Shortfall at Barclays
Barclays says it will exceed the 7% capital requirement by the end of the year.
Regulator Identifies £13.6bn Capital Shortfall at Royal Bank of Scotland
Royal Bank of Scotland Group reckons existing plans leave it needing just an extra £0.4 billion.
Regulator Identifies £8.6bn Capital Shortfall at Lloyds
Lloyds Banking Group reckons it needs to find an extra £2.8 billion.
easyJet Confirms Purchase of up to 235 New Planes
easyJet selects Airbus to help increase passenger numbers and reduce costs.
Aggreko Confirms Revenue Up 5%
Aggreko admits that first-half profit has stagnated.
Halma Lifts Dividend for 34th Consecutive Year
Halma reports record results and extends its illustrious payout.
Stephen Hester to Leave Royal Bank of Scotland
Royal Bank of Scotland Group announces the departure of its chief executive.
ASOS Reveals Sales Up 43%
ASOS delivers bumper third-quarter figures.
Vodafone Group Confirms Kabel Deutschland Approach
Vodafone Group announces the approach on ex-div day.
IG Group Holdings Reports Q4 Revenue Up 8%
IG Group Holdings benefits from events in Cyprus and the gold-price fall.
Severn Trent Rejects £22 Per Share Offer
Bidders claim Severn Trent has shown "no interest" in the proposal and may now walk away.
AstraZeneca to Spend Up to $1.15 Billion on New Acquisition
AstraZeneca announces the purchase of an American developer of asthma treatments.
Quindell Portfolio Announces 25 Million Pound Contract Win
Quindell Portfolio announces yet another "major" contract.
Tesco Shares Slide as Like-for-Like U.K. Sales Drop 1%
Tesco blames its "disproportionate exposure to consumer electronics" for a weak first quarter.
Moneysupermarket.com Group Declares £70m Special Dividend As Founder Sells Shares for £160m
Moneysupermarket.com Group reveals sales have advanced by more than 10% so far this year.
AstraZeneca Writes Off $140 Million Following Product Trial
AstraZeneca admits that trials of a treatment for rheumatoid arthritis did not meet expectations.
Gulf Keystone Petroleum Issues Update on Move to Official List
Gulf Keystone Petroleum announces it will split the roles of chairman and chief executive.
AstraZeneca Acquires Omthera Pharmaceuticals for Up to $443 Million
AstraZeneca announces the purchase of Omthera Pharmaceuticals.
Lloyds Raises £450m Following Further St. James's Place Share Disposal
Lloyds Banking Group sells 77 million shares in St James's Place.